3US Renal Data System:USRDS 2002 Annual Data Report.Bethesda,National Institutes of Health,National Institute of Diabetes and Digestive and Kidney Diseases,2002,chapt 4. 被引量：1
5Centers for Medicare and Medicaid Services:2005 Annual Report,End Stage Renal Disease Clinical Performance Measures Project.Baltimore,Department of Health and Human Services,Centers for Medicare and Medicaid Services,Center for Beneficiary Choices,2005. 被引量：1
6Quarello F,Forneris G,Borca M,et al.Do central venous catheters have advantages over arteriovenous fistulas or grafts[J]? J Nephrol,2006,19:265-279. 被引量：1
7Dhingra RK,Young EW,Hulbert-Shearon TE,et al.Type of vascular acess and mortality in US hemodialysis patients[J].Kidney Int,2001,60:1443-1451. 被引量：1
8Pastan S,Soucie JM,McClellan WM:Vascular access and increasing risk of death among vascular access patients[J].Kidney Int,2002,62:620-626. 被引量：1
9Kite P.Rapid diagnosis of central-venous-catheter-relatde bloodstream infection without catheter removal[J].Lancet,1999,354:1504-1507. 被引量：1
10Oliver M,Callery S,Thorpe K,et al.Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use:A prospective study[J].Kidney Int,2000,58:2543-2545. 被引量：1
